GlassScriptPhysician profile
Suhas Badarinath
NPI 1821133323
$15,727.51
in general payments reported to CMS, 2019-2025
34 companies · $2,672 in 2025
The $2,672 reported for 2025 was more than what 95% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,346 · 2020: $2,293 · 2021: $1,409 · 2022: $2,492 · 2023: $2,825 · 2024: $2,690 · 2025: $2,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,240 · Travel and Lodging: $830 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,239.72 |
| Travel and Lodging | $829.70 |
| Education | $117.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,841.23 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $2,617.69 | 2019-2025 | Proclaim |
| Globus Medical, INC. | $1,327.53 | 2025 | Senza, Vyrsa V1, Omnia |
| Nalu Medical, INC. | $1,298.75 | 2022-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $1,199.76 | 2019-2020 | |
| Spinal Simplicity, LLC | $1,036.26 | 2022-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $1,004.07 | 2020-2024 | Senza |
| Collegium Pharmaceutical, INC. | $789.61 | 2019-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $745.36 | 2019-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $627.34 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $578.84 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Spectra Wavewriter |
| Foundation Fusion Solutions, LLC | $300.46 | 2024-2025 | |
| Horizon Therapeutics Plc | $234.40 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $226.77 | 2019-2021 | |
| Curonix LLC | $160.19 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $123.62 | 2020-2023 | Zubsolv |
| Vertos Medical, INC. | $109.93 | 2023-2024 | Mild Device Kit |
| Avanos Medical | $65.06 | 2024 | Generator |
| Forte Bio-Pharma LLC | $45.56 | 2021 | |
| Redhill Biopharma INC. | $44.39 | 2020-2021 | |
| Electronic Waveform Lab, INC. | $39.43 | 2019-2025 | |
| Pfizer INC. | $36.84 | 2019 | |
| Hikma Pharmaceuticals USA | $34.39 | 2022 | |
| Sentynl Therapeutics, INC. | $34.33 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $31.67 | 2025 | |
| Almatica Pharma LLC | $26.32 | 2023 | Gralise |
| Cumberland Pharmaceuticals, INC. | $25.49 | 2024 | Kristalose |
| Tersera Therapeutics LLC | $19.77 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.47 | 2022 | |
| Ibsa Pharma INC. | $19.41 | 2023 | Tirosint, Licart |
| Indivior INC. | $18.81 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.30 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.81 | 2019 | |
| Painteq LLC | $13.65 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhas Badarinath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.